Medical Device News

Medical Device News Magazine delivers the latest medical device news and MedTech industry updates from medical device manufacturers, healthcare organizations, researchers, innovators and technology companies worldwide. Our coverage follows the technologies, companies, regulatory developments and clinical advances shaping the rapidly evolving global medical device industry.

Stay informed about new medical devices, product launches, FDA approvals and clearances, medical device clinical trials, medical imaging technologies, artificial intelligence, digital health, cardiovascular devices, surgical technologies, diagnostics, patient monitoring systems, robotics and other emerging medical technologies designed to advance patient care and clinical practice.

Our coverage extends beyond product innovation to include the business and regulatory developments influencing the medical device industry. Medical Device News Magazine reports on FDA regulatory developments, 510(k) clearances, Premarket Approvals (PMA), medical device recalls and safety information, funding and investment, mergers and acquisitions, executive appointments, strategic partnerships and market developments affecting established manufacturers and emerging MedTech companies.

As healthcare becomes increasingly connected, data-driven and technology-focused, Medical Device News Magazine provides timely industry information for medical specialists, healthcare professionals, medical device executives, investors and other MedTech stakeholders who want to understand the technologies and companies influencing the future of healthcare.

Explore the latest Medical Device News below for updates on innovative medical technologies, FDA regulatory milestones, clinical research, product introductions, industry partnerships and companies developing the next generation of medical devices.

Glytec

Glytec Unveils the Next Evolution of GlucoMetricsⓇ, Giving Hospital Leaders New Insights and Analytics to Improve Glycemic Management and Readiness for New CMS Measures

“CMS is making it clear that hypoglycemia related to insulin is largely preventable, and early treatment and optimal management of severe hyperglycemia is a priority. But it’s hard to enact and measure this type of change without access to data, or the expertise to turn that data into actionable insights,” said Jordan Messler, MD, Chief Medical Officer at Glytec.

Read More »